Celaid Therapeutics Overview
- Year Founded
-
2020
- Status
-
Private
- Employees
-
20
- Latest Deal Type
-
Series B
- Latest Deal Amount
-
$9.3M
- Investors
-
16
Celaid Therapeutics General Information
Description
Developer of a regenerative medicine platform designed to develop cell therapy products. The company's platform delivers medicines created using human hematopoietic stem cell expansion technology and provides research support for media reagents, enabling medical professionals to combine hematopoietic stem cell transplantation and cell therapy products with gene-editing technology.
Contact Information
Website
www.celaidtx.comCorporate Office
- Entrepreneur Lab, South Research Building, The University of Tokyo
- 7-3-1 Hongo, Bunkyo-ku
- Tokyo, 113-8485
- Japan
Corporate Office
- Entrepreneur Lab, South Research Building, The University of Tokyo
- 7-3-1 Hongo, Bunkyo-ku
- Tokyo, 113-8485
- Japan
Celaid Therapeutics Timeline
Celaid Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 10. Later Stage VC (Series B) | 04-Oct-2026 | $9.3M | Completed | Generating Revenue | ||
| 9. Early Stage VC (Series A) | 29-Oct-2024 | Completed | Generating Revenue | |||
| 8. Secondary Transaction - Private | Completed | Generating Revenue | ||||
| 7. Grant | 22-Mar-2024 | Completed | Generating Revenue | |||
| 6. Accelerator/Incubator | 16-Jan-2023 | Completed | Generating Revenue | |||
| 5. Accelerator/Incubator | 22-Dec-2021 | Completed | Generating Revenue | |||
| 4. Accelerator/Incubator | 02-Jul-2021 | Completed | Generating Revenue | |||
| 3. Accelerator/Incubator | 20-Oct-2020 | Completed | Startup | |||
| 2. Accelerator/Incubator | Completed | Startup | ||||
| 1. Accelerator/Incubator | 01-Jan-2020 | Completed | Startup |
Celaid Therapeutics Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| A Preferred |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
Celaid Therapeutics Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Celaid Therapeutics Patents
Celaid Therapeutics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026079443-A1 | Method for inducing or producing cxcr4-positive hematopoietic stem cells, and cell population including said cxcr4-positive hematopoietic stem cells | Pending | 09-Oct-2024 | ||
| WO-2025159194-A1 | Composition, culture medium, cell population, cell production method, and therapeutic drug | Pending | 25-Jan-2024 | ||
| JP-2026119269-A | Compositions, culture media, cell populations, methods for producing cells, and therapeutic drugs | Pending | 25-Jan-2024 | ||
| JP-7870044-B2 | Compositions, culture media, cell populations, methods for producing cells, and therapeutic drugs | Active | 25-Jan-2024 | ||
| JP-7734361-B2 | Compound or salt thereof and method for producing same, pharmaceutical composition containing compound or salt thereof and method for producing same | Active | 05-Sep-2023 | A61K31/519 |
Celaid Therapeutics Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Celaid Therapeutics Investors (16)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Japan Agency for Medical Research and Development | Government | Minority | ||
| Shionogi | Corporation | Minority | ||
| Teikoku Ventures | Corporate Venture Capital | Minority | ||
| Joyo Capital Partners | Corporate Venture Capital | Minority | ||
| Kobe University Capital | Venture Capital | Minority |
Celaid Therapeutics FAQs
-
When was Celaid Therapeutics founded?
Celaid Therapeutics was founded in 2020.
-
Where is Celaid Therapeutics headquartered?
Celaid Therapeutics is headquartered in Tokyo, Japan.
-
What is the size of Celaid Therapeutics?
Celaid Therapeutics has 20 total employees.
-
What industry is Celaid Therapeutics in?
Celaid Therapeutics’s primary industry is Drug Discovery.
-
Is Celaid Therapeutics a private or public company?
Celaid Therapeutics is a Private company.
-
What is the current valuation of Celaid Therapeutics?
The current valuation of Celaid Therapeutics is .
-
What is Celaid Therapeutics’s current revenue?
The current revenue for Celaid Therapeutics is .
-
How much funding has Celaid Therapeutics raised over time?
Celaid Therapeutics has raised $16.7M.
-
Who are Celaid Therapeutics’s investors?
Japan Agency for Medical Research and Development, Shionogi, Teikoku Ventures, Joyo Capital Partners, and Kobe University Capital are 5 of 16 investors who have invested in Celaid Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
